Dapsone

Chemical formula: C₁₂H₁₂N₂O₂S  Molecular mass: 248.301 g/mol  PubChem compound: 2955

Therapeutic indications

Dapsone is indicated for:

Multibacillary leprosy

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Multibacillary leprosy

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Paucibacillary leprosy

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Paucibacillary leprosy

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Malaria prophylaxis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Preventive procedure and additionally Malaria

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Dermatitis herpetiformis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Dermatitis herpetiformis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Pneumocystis carinii pneumonia

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Pneumocystis carinii and additionally Fungal pneumonia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Multibacillary leprosy

Population group: only children (1 year - 12 years old)

Multibacillary leprosy

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Paucibacillary leprosy

Population group: only children (1 year - 12 years old)

Paucibacillary leprosy

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Dapsone is contraindicated in the following cases:

Severe anaemia, porphyria, severe glucose-6-phosphate dehydrogenase deficiency

at least one of
Anemia
Porphyria
Glucose-6-phosphate dehydrogenase deficiency anemia
Deficiency of glucose-6-phosphate dehydrogenase

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2019: ACZONE Gel
Summary of Product Characteristics (SPC) 2019: DAPSONE Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈